Hospital Britanico

Buenos Aires CP 1280

1 studies enrolling now · 12 studies all time

What they study most

Advanced Cholangiocarcinoma, Carcinoma, Non-small-cell Lung, Chronic Idiopathic Thrombocytopenic Purpura, Chronic Myeloid Leukemia, FGFR2 Fusions, Gene Rearrangement, Guillain-Barré Syndrome, KRAS G12C Lung Cancer, Miller Fisher Syndrome, Non-Small Cell Lung Cancer, Pancreatic Cancer, Pulmonary Arterial Hypertension

Studies at this site

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation — Recruiting now
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
International Guillain-Barré Syndrome Outcome Study — Completed
A Study of ARRY-438162 in Patients With Rheumatoid Arthritis — Completed
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias — Completed
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed